TRIM5 Inhibitors
The inhibitors listed above target various aspects of viral replication, host cell entry, and cellular processes, which could indirectly influence TRIM5 activity. Given TRIM5's involvement in innate immunity and retroviral restriction, these compounds are relevant for understanding its function and potential modulation. Chloroquine and Hydroxychloroquine, by affecting endosomal acidification, could indirectly influence the ability of TRIM5 to restrict viral entry and uncoating. Bafilomycin A1, targeting the vacuolar-type H+-ATPase, might also impact endosomal processes relevant to TRIM5's antiviral activity.
CCR5 antagonists like TAK-779 and Maraviroc, as well as HIV-1 protease inhibitors (Lopinavir, Ritonavir) and reverse transcriptase inhibitors (Zidovudine, Efavirenz), affect HIV-1 entry and replication, potentially impacting TRIM5's role in viral restriction. Interferon-alpha, known for enhancing immune responses, could modulate TRIM5's function in the antiviral defense mechanism. JQ1, affecting gene expression, and MG132, impacting ubiquitination processes, might indirectly influence the regulation and function of TRIM5.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Similar to Chloroquine, Hydroxychloroquine may affect endosomal pathways and thus indirectly impact TRIM5 function. | ||||||
Lopinavir | 192725-17-0 | sc-207831 | 10 mg | $132.00 | 6 | |
Lopinavir, an HIV-1 protease inhibitor, can indirectly influence TRIM5 function by affecting viral replication. | ||||||
Ritonavir | 155213-67-5 | sc-208310 | 10 mg | $124.00 | 7 | |
Ritonavir, also an HIV-1 protease inhibitor, might have an indirect impact on TRIM5-mediated viral restriction. | ||||||
3′-Azido-3′-deoxythymidine | 30516-87-1 | sc-203319 | 10 mg | $61.00 | 2 | |
Zidovudine, a nucleoside reverse transcriptase inhibitor, can affect HIV-1 replication, potentially impacting TRIM5 activity. | ||||||
Efavirenz | 154598-52-4 | sc-207612 | 10 mg | $171.00 | 3 | |
Efavirenz, a non-nucleoside reverse transcriptase inhibitor, might indirectly influence TRIM5's antiviral activity. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1, a BET bromodomain inhibitor, could influence gene expression and potentially affect TRIM5 function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132, a proteasome inhibitor, might impact the ubiquitination processes related to TRIM5 function. | ||||||